Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tommysdad who wrote (22707)	6/25/1998 7:16:00 PM
From: Hippieslayer	Read Replies (1) \| Respond to of 32384

Yeah, I did miss it. But, you know that it isn't good when they only mention rat once. Had they mentioned it several times, them maybe we would have seen a huge explosion in the price tomorrow. But, if we are lucky, we'll probably see gain of about a half.

To: tommysdad who wrote (22707)	6/25/1998 10:27:00 PM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Actually, all of the androgen data is pre-clinical (IND expected later this year with trials beginning early next year), but the markets are huge and at this time it's all LGND. Not sure if they will partner some of this out, but they are making remarkable progress in many areas and unlike the SERMs (where LGND has programs with LLY on Evista, PFE on Droloxifene and CP-366,156, and AHP on TSE424), so far LGND has grabbed the ball and is running with it on the SARMs.